Silence Therapeutics
Develops siRNA medicines that silence disease-causing genes, with programmes in polycythemia vera and high Lp(a).
silence-therapeutics.com ↗Why it's here
Raised about $201M in an upsized US public offering of ADSs in August 2026.
source: goodwinlaw.com- Focus
- siRNA therapeutics
- Founded
- 1994
- Latest round
- Public offering, $201M, Aug 2026
- Team size
- 51-200 people
- London office
- 12 Hammersmith Grove, London, Hammersmith and Fulham W6 7APsource: silence-therapeutics.com
- London presence
- HQsource: silence-therapeutics.com
- Nearest station
- Hammersmith, 256 m
Verified 8 Oct 2026. How we verify · Suggest a fix
For Silence Therapeutics
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/silence-therapeutics"><img src="https://londonmempool.co.uk/badge/silence-therapeutics.svg" alt="Silence Therapeutics is listed on London Mempool" width="361" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.